Literature DB >> 25667222

Adrenergic and serotonin receptors affect retinal superoxide generation in diabetic mice: relationship to capillary degeneration and permeability.

Yunpeng Du1, Megan Cramer1, Chieh Allen Lee1, Jie Tang1, Arivalagan Muthusamy1, David A Antonetti1, Hui Jin1, Krzysztof Palczewski1, Timothy S Kern2.   

Abstract

Reactive oxygen species play an important role in the pathogenesis of diabetic retinopathy. We studied the role of adrenergic and serotonin receptors in the generation of superoxide by retina and 661W retinal cells in high glucose and of the α1-adrenergic receptor (AR) on vascular lesions of the retinopathy in experimentally diabetic C57Bl/6J mice (and controls) after 2 and 8 months. Compared with 5 mM glucose, incubating cells or retinal explants in 30 mM glucose induced superoxide generation. This response was reduced or ablated by pharmacologic inhibition of the α1-AR (a Gq-coupled receptor) or Gs-coupled serotonin (5-HT2, 5-HT4, 5-HT6, and 5-HT7) receptors or by activation of the Gi-coupled α2-AR. In elevated glucose, the α1-AR produced superoxide via phospholipase C, inositol triphosphate-induced Ca(2+) release, and NADPH oxidase, and pharmacologic inhibition of these reactions prevented the superoxide increase. Generation of retinal superoxide, expression of proinflammatory proteins, and degeneration of retinal capillaries in diabetes all were significantly inhibited with daily doxazosin or apocynin (inhibitors of α1-AR and NADPH oxidase, respectively), but increased vascular permeability was not significantly affected. Adrenergic receptors, and perhaps other GPCRs, represent novel targets for inhibiting the development of important features of diabetic retinopathy. © FASEB.

Entities:  

Keywords:  GPCRs; NADPH oxidase; diabetic retinopathy; inflammation

Mesh:

Substances:

Year:  2015        PMID: 25667222      PMCID: PMC4415023          DOI: 10.1096/fj.14-269431

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  61 in total

1.  Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology.

Authors:  Timothy S Kern; Casey M Miller; Yunpeng Du; Ling Zheng; Susanne Mohr; Sherry L Ball; M Kim; Jeffrey A Jamison; David P Bingaman
Journal:  Diabetes       Date:  2007-02       Impact factor: 9.461

2.  NADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy.

Authors:  Jennifer L Wilkinson-Berka; Devy Deliyanti; Indrajeetsinh Rana; Antonia G Miller; Alex Agrotis; Roksana Armani; Cédric Szyndralewiez; Kirstin Wingler; Rhian M Touyz; Mark E Cooper; Karin A Jandeleit-Dahm; Harald H H W Schmidt
Journal:  Antioxid Redox Signal       Date:  2013-10-30       Impact factor: 8.401

3.  Role of oxidative stress in high-glucose- and diabetes-induced increased expression of Gq/11α proteins and associated signaling in vascular smooth muscle cells.

Authors:  Magda Descorbeth; Madhu B Anand-Srivastava
Journal:  Free Radic Biol Med       Date:  2010-08-05       Impact factor: 7.376

4.  Effects of p38 MAPK inhibition on early stages of diabetic retinopathy and sensory nerve function.

Authors:  Yunpeng Du; Jie Tang; Guangyuan Li; Guanyuan Li; Liliana Berti-Mattera; Chieh Allen Lee; Darian Bartkowski; David Gale; Joe Monahan; Michael R Niesman; Gordon Alton; Timothy S Kern
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-13       Impact factor: 4.799

5.  Early alterations of Gi/Go protein-dependent transductional processes in the retina of diabetic animals.

Authors:  M P Abbracchio; F Cattabeni; A M Di Giulio; C Finco; A M Paoletti; B Tenconi; A Gorio
Journal:  J Neurosci Res       Date:  1991-06       Impact factor: 4.164

6.  The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints.

Authors:  Robert Fredriksson; Malin C Lagerström; Lars-Gustav Lundin; Helgi B Schiöth
Journal:  Mol Pharmacol       Date:  2003-06       Impact factor: 4.436

7.  Diabetes-induced impairment in visual function in mice: contributions of p38 MAPK, rage, leukocytes, and aldose reductase.

Authors:  Chieh Allen Lee; Guangyuan Li; Mansi D Patel; J Mark Petrash; Beth Ann Benetz; Alex Veenstra; Jaume Amengual; Johannes von Lintig; Christopher J Burant; Johnny Tang; Timothy S Kern
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-02       Impact factor: 4.799

8.  Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes.

Authors:  L Zheng; Y Du; C Miller; R A Gubitosi-Klug; T S Kern; S Ball; B A Berkowitz
Journal:  Diabetologia       Date:  2007-06-22       Impact factor: 10.122

9.  Systemic propranolol reduces b-wave amplitude in the ERG and increases IGF-1 receptor phosphorylation in rat retina.

Authors:  Youde Jiang; Jena J Steinle
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-30       Impact factor: 4.799

10.  β2-adrenergic receptor knockout mice exhibit A diabetic retinopathy phenotype.

Authors:  Youde Jiang; Qiuhua Zhang; Li Liu; Jie Tang; Timothy S Kern; Jena J Steinle
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

View more
  32 in total

Review 1.  Systems Pharmacology Links GPCRs with Retinal Degenerative Disorders.

Authors:  Yu Chen; Krzysztof Palczewski
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-03-23       Impact factor: 13.820

2.  Neutrophil elastase contributes to the pathological vascular permeability characteristic of diabetic retinopathy.

Authors:  Haitao Liu; Emma M Lessieur; Aicha Saadane; Sarah I Lindstrom; Patricia R Taylor; Timothy S Kern
Journal:  Diabetologia       Date:  2019-10-14       Impact factor: 10.122

Review 3.  Pathophysiology of Diabetic Retinopathy: Contribution and Limitations of Laboratory Research.

Authors:  Timothy S Kern; David A Antonetti; Lois E H Smith
Journal:  Ophthalmic Res       Date:  2019-07-30       Impact factor: 2.892

4.  PERK and XBP1 differentially regulate CXCL10 and CCL2 production.

Authors:  Shuang Zhu; Hua Liu; Haibo Sha; Ling Qi; Dian-Shuai Gao; Wenbo Zhang
Journal:  Exp Eye Res       Date:  2017-01-05       Impact factor: 3.467

5.  Photoreceptor cells produce inflammatory products that contribute to retinal vascular permeability in a mouse model of diabetes.

Authors:  Deoye Tonade; Haitao Liu; Krzysztof Palczewski; Timothy S Kern
Journal:  Diabetologia       Date:  2017-07-28       Impact factor: 10.122

6.  Modulation of α-adrenoceptor signalling protects photoreceptors after retinal detachment by inhibiting oxidative stress and inflammation.

Authors:  Tong Li; Shiqi Yang; Xiangjun She; Quan Yan; Pengfei Zhang; Hong Zhu; Fenghua Wang; Xueting Luo; Xiaodong Sun
Journal:  Br J Pharmacol       Date:  2019-01-30       Impact factor: 8.739

7.  Systemic Retinaldehyde Treatment Corrects Retinal Oxidative Stress, Rod Dysfunction, and Impaired Visual Performance in Diabetic Mice.

Authors:  Bruce A Berkowitz; Timothy S Kern; David Bissig; Priya Patel; Ankit Bhatia; Vladimir J Kefalov; Robin Roberts
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-10       Impact factor: 4.799

Review 8.  Mechanistic Insights into Pathological Changes in the Diabetic Retina: Implications for Targeting Diabetic Retinopathy.

Authors:  Sayon Roy; Timothy S Kern; Brian Song; Caren Stuebe
Journal:  Am J Pathol       Date:  2016-11-12       Impact factor: 4.307

9.  Retinylamine Benefits Early Diabetic Retinopathy in Mice.

Authors:  Haitao Liu; Jie Tang; Yunpeng Du; Chieh Allen Lee; Marcin Golczak; Arivalagan Muthusamy; David A Antonetti; Alexander A Veenstra; Jaume Amengual; Johannes von Lintig; Krzysztof Palczewski; Timothy S Kern
Journal:  J Biol Chem       Date:  2015-07-02       Impact factor: 5.157

Review 10.  Do photoreceptor cells cause the development of retinal vascular disease?

Authors:  Timothy S Kern
Journal:  Vision Res       Date:  2017-05-08       Impact factor: 1.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.